Literature DB >> 26687156

Catechol-O-Methyltransferase Gene Polymorphisms in Specific Obsessive-Compulsive Disorder Patients' Subgroups.

Fernanda Brito Melo-Felippe1, Juliana Braga de Salles Andrade2,3, Isabele Gomes Giori1, Tamiris Vieira-Fonseca1, Leonardo Franklin Fontenelle2,3,4, Fabiana Barzotti Kohlrausch5.   

Abstract

Pharmacological data and animal models support the hypothesis that the dopaminergic (DA) system is implicated in obsessive-compulsive disorder (OCD). Therefore, this case-control study assessed whether genetics variations in catechol-O-methyltransferase gene (COMT) could influence susceptibility to OCD and OCD features in a Brazilian sample. A sample of 199 patients with OCD and 200 healthy individuals was genotyped for -287A > G (rs2075507) and Val158Met (rs4680) single nucleotide polymorphisms (SNPs) by TaqMan(®) or restriction mapping. We observed a statistically significant predominance of the Met low-activity allele in the male patient group as compared to the male healthy control group. The -287A > G polymorphism's genotypes and alleles were significantly overrepresented among male individuals with ordering and female subjects with washing symptoms. We also found female hoarders to exhibit a significant higher frequency of the low activity Met/Met genotype of Val158Met polymorphism compared to female patients who did not express this dimension. Our data suggest an influence of COMT polymorphisms on OCD and OCD patients' features, such as gender, and ordering, washing, and hoarding symptom dimensions. Further studies to confirm the clinical importance of COMT SNPs in OCD are warranted.

Entities:  

Keywords:  Brazil; COMT; Dopamine; Genetics; Obsessive–compulsive disorder; SNP

Mesh:

Substances:

Year:  2015        PMID: 26687156     DOI: 10.1007/s12031-015-0697-0

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  60 in total

Review 1.  New developments in obsessive-compulsive disorder research: implications for clinical management.

Authors:  Y Sasson; J Zohar
Journal:  Int Clin Psychopharmacol       Date:  1996-12       Impact factor: 1.659

2.  Association between the COMT locus and obsessive-compulsive disorder in females but not males.

Authors:  John P Alsobrook; Ada H Zohar; Marion Leboyer; Nadia Chabane; Richard P Ebstein; David L Pauls
Journal:  Am J Med Genet       Date:  2002-01-08

Review 3.  Gender differences in obsessive-compulsive disorder: a literature review.

Authors:  Maria Alice de Mathis; Pedro de Alvarenga; Guilherme Funaro; Ricardo Cezar Torresan; Ivanil Moraes; Albina Rodrigues Torres; Monica L Zilberman; Ana Gabriela Hounie
Journal:  Braz J Psychiatry       Date:  2011-12       Impact factor: 2.697

4.  Family-based association studies support a sexually dimorphic effect of COMT and MAOA on genetic susceptibility to obsessive-compulsive disorder.

Authors:  M Karayiorgou; C Sobin; M L Blundell; B L Galke; L Malinova; P Goldberg; J Ott; J A Gogos
Journal:  Biol Psychiatry       Date:  1999-05-01       Impact factor: 13.382

Review 5.  Second-generation antipsychotics for obsessive compulsive disorder.

Authors:  Katja Komossa; Anna M Depping; Magdalena Meyer; Werner Kissling; Stefan Leucht
Journal:  Cochrane Database Syst Rev       Date:  2010-12-08

6.  D-amphetamine in obsessive-compulsive disorder.

Authors:  T R Insel; J A Hamilton; L B Guttmacher; D L Murphy
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

7.  Risperidone augmentation in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled study.

Authors:  Eric Hollander; Nicolò Baldini Rossi; Erica Sood; Stefano Pallanti
Journal:  Int J Neuropsychopharmacol       Date:  2003-12       Impact factor: 5.176

8.  Factor analysis of symptom subtypes of obsessive compulsive disorder and their relation to personality and tic disorders.

Authors:  L Baer
Journal:  J Clin Psychiatry       Date:  1994-03       Impact factor: 4.384

9.  The genomic ancestry of individuals from different geographical regions of Brazil is more uniform than expected.

Authors:  Sérgio D J Pena; Giuliano Di Pietro; Mateus Fuchshuber-Moraes; Julia Pasqualini Genro; Mara H Hutz; Fernanda de Souza Gomes Kehdy; Fabiana Kohlrausch; Luiz Alexandre Viana Magno; Raquel Carvalho Montenegro; Manoel Odorico Moraes; Maria Elisabete Amaral de Moraes; Milene Raiol de Moraes; Elida B Ojopi; Jamila A Perini; Clarice Racciopi; Andrea Kely Campos Ribeiro-Dos-Santos; Fabrício Rios-Santos; Marco A Romano-Silva; Vinicius A Sortica; Guilherme Suarez-Kurtz
Journal:  PLoS One       Date:  2011-02-16       Impact factor: 3.240

Review 10.  Obsessive-compulsive disorder and its related disorders: a reappraisal of obsessive-compulsive spectrum concepts.

Authors:  Dennis L Murphy; Kiara R Timpano; Michael G Wheaton; Benjamin D Greenberg; Euripedes C Miguel
Journal:  Dialogues Clin Neurosci       Date:  2010       Impact factor: 5.986

View more
  5 in total

1.  Genetics of OCD and Related Disorders; Searching for Shared Factors.

Authors:  Edna Grünblatt
Journal:  Curr Top Behav Neurosci       Date:  2021

2.  Association analyses reveal gender-specific associations of DAT1 40-bp VNTR and -839C/T polymorphisms with obsessive-compulsive disorder and obsessive-compulsive symptoms.

Authors:  Juliana C Cotrin; Leonardo F Fontenelle; Fabiana B Kohlrausch
Journal:  Mol Biol Rep       Date:  2019-07-19       Impact factor: 2.316

3.  Pro-dopamine regulator, KB220Z, attenuates hoarding and shopping behavior in a female, diagnosed with SUD and ADHD.

Authors:  Thomas McLaughlin; Kenneth Blum; Bruce Steinberg; Edward J Modestino; Lyle Fried; David Baron; David Siwicki; Eric R Braverman; Rajendra D Badgaiyan
Journal:  J Behav Addict       Date:  2018-01-10       Impact factor: 6.756

4.  Looking into the genetic bases of OCD dimensions: a pilot genome-wide association study.

Authors:  María Alemany-Navarro; Raquel Cruz; Eva Real; Cinto Segalàs; Sara Bertolín; Raquel Rabionet; Ángel Carracedo; Jose M Menchón; Pino Alonso
Journal:  Transl Psychiatry       Date:  2020-05-18       Impact factor: 6.222

Review 5.  Psychopharmacological Treatment of Obsessive-Compulsive Disorder (OCD).

Authors:  Antonio Del Casale; Serena Sorice; Alessio Padovano; Maurizio Simmaco; Stefano Ferracuti; Dorian A Lamis; Chiara Rapinesi; Gabriele Sani; Paolo Girardi; Georgios D Kotzalidis; Maurizio Pompili
Journal:  Curr Neuropharmacol       Date:  2019       Impact factor: 7.363

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.